ZIKAction Preparedness research and action network on maternal paediatric axis...
ZIKAction Preparedness research and action network on maternal paediatric axis of ZIKV infection in Latin America and the Caribbean
ZIKAction proposes to set up a multidisciplinary research network across Latin America with a focus on maternal and child health to coordinate and implement urgent research against the current ZIKV outbreak and lay the foundation...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ZikaPLAN
Zika Preparedness Latin American Network
13M€
Cerrado
ZIKAlliance
A global alliance for Zika virus control and prevention
16M€
Cerrado
ZIKAVAX
Fast track development of a Zika vaccine based on measles ve...
5M€
Cerrado
WINGS
West Nile Integrated Shield Project Epidemiology Diagnosis...
4M€
Cerrado
PREGVAX
Plasmodium Vivax Infection in Pregnancy
4M€
Cerrado
PROMISE-ZERO
Implementation of an upgraded strategy to reach zero HIV tra...
4M€
Cerrado
Información proyecto ZIKAction
Duración del proyecto: 58 meses
Fecha Inicio: 2016-11-16
Fecha Fin: 2021-09-30
Líder del proyecto
FONDAZIONE PENTA ETS
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
7M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
ZIKAction proposes to set up a multidisciplinary research network across Latin America with a focus on maternal and child health to coordinate and implement urgent research against the current ZIKV outbreak and lay the foundation for a preparedness research network against future emerging severe infectious threats in these vulnerable populations. Our Consortium brings together Latin American and European leaders in paediatric infectious disease research, including virologists, epidemiologists, immunologists and obstetric, neonatal and paediatric practitioners, all with a wealth of experience in vertical transmission (VT) studies, a group uniquely placed to evaluate the potentially causative relationship between ZIKV and severe reported complications. ZIKAction will collect data from prospective cohorts of pregnant women and infants to assess ZIKV complications with the necessary level of evidence which is currently lacking. Complementary work in virology will take advantage of repeated biological samples from these cohorts, while pathogenesis studies on animal models will elucidate risk factors and mechanisms of VT. Partners’ experience in conducting trials among pregnant women and children and close contact with other relevant researchers will allow rapid launch of additional interventional studies, including the addition of sites and partners, to address remaining research gaps against ZIKV. Recognizing the breadth and complexity of the research questions presented by the current ZIKV epidemic and the potential for future severe emerging infectious threats, ZIKAction will actively seek out collaborations with relevant initiatives already existing or under development to maximize synergy and avoid duplication of efforts. Our focus on vertical transmission and maternal and child health would nicely complement a range of other activities including clinical and laboratory studies in the general population, surveillance, and work in public health and prevention.